Star Wars Box Office Haul Exceeds Projections but Lands on Low End of DisneyEra Openings
Stock Market Today Indices Show Mixed Performance Amid Earnings Season Focus
SEBI Chief Tuhin Kanta Pandey Highlights Indias Diversified Market Amid Taiwans Ascent on TSMC and AI Boom
Intuits Latest Earnings Results Test Morgan Stanleys Stock Projection
Trump Seeks Supreme Court Intervention to Halt Imminent TikTok Ban
Workday Rises on Margin Forecast Boost Amid AI Momentum
CGBD Q1 2026 Earnings Narrow EPS Miss Amid Stable Credit Performance
Bicara Therapeutics BCAX Q1 2026 Earnings EPS Miss Overshadowed by Pipeline Progress as Stock Rises 4
Runway Growth Finance Corp RWAY Q1 2026 Earnings EPS Misses Estimates as Stock Holds Steady
Six Flags Entertainment Q1 2026 Earnings Narrowerthanexpected loss amid seasonal headwinds
FCPT Q1 2026 Earnings EPS Misses Estimates Amid Market Headwinds
KRNY Q1 2026 Earnings EPS Misses Estimates Amid Cautious Quarter
AvePoint AVPT Edges Higher Amid Steady Trading Key Support and Resistance Levels in Focus
POMDOCTOR Limited POM Shares Slide 11 as Stock Nears Critical 010 Floor
American International Group AIG Shows Modest Gains as Stock Hovers Between Key Levels
Core Scientific Warrants CORZW Surge Over 5 Key Levels to Watch
Alliance Entertainment Holding Corporation Warrant AENTW Gains 463 Approaches Key Resistance at 053
Mark Cuban Warns Healthcare Conglomerates Abuse Power Calls for Antitrust Enforcement
NAGE Q1 2026 Earnings EPS Beats Estimates by a Slim Margin Stock Declines
Mueller Water Products MWA Holds Steady Near Resistance as Small Gains Persist
NACCO Industries NC Q1 2026 Earnings EPS of 117 Reported Amid Limited Disclosure
REVB Q1 2026 Earnings WiderthanExpected Loss Highlights PreRevenue Challenges
HDB Q1 FY2026 Earnings EPS Surpasses Estimates by 073
ODD Q4 2025 Earnings Earnings Beat on Strong EPS Surprise
AUTL Q1 2026 Earnings Biotech Posts WiderThanExpected Loss as Stock Edges Higher
Energous Corporation WATT Q1 2026 Earnings EPS Surprises to the Upside Amid Zero Revenue Quarter
SGMO Q1 2026 Earnings Gene Therapy Focus Drives Stock Higher Despite Deep EPS Miss